Iguratimod Dampens B cell Terminal Differentiation by Inhibiting Egr-1 expression
收藏NIAID Data Ecosystem2026-04-25 收录
官方服务：
资源简介：
Iguratimod is a small molecule drug to inhibit B cell terminal differentiation and to treat rheumatoid arthritis (RA) in Asia, but its work mechanism remains highly controversial. This study is aimed to explore the potential molecular mechanism of iguratimod in dampening human ASC differentiation and its relevance in clinical situation.
创建时间：
2019-08-04
